{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:26:11Z","timestamp":1773833171119,"version":"3.50.1"},"reference-count":30,"publisher":"BMJ","issue":"19","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2015,7,3]]},"published-print":{"date-parts":[[2015,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Patients with chronic kidney disease (CKD) are at high risk of death or myocardial infarction (MI) after percutaneous coronary interventions (PCI). We assessed whether prolonged dual antiplatelet therapy beyond the recommended 12\u2005months may prevent adverse outcomes in patients with CKD receiving drug-eluting stents (DES) or bare-metal stents (BMS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We studied all Veterans receiving PCI with BMS or first-generation DES in the Veterans Affairs (VA) Healthcare System between 2002 and 2006, classified by CKD (estimated glomerular filtration rate &lt;60\u2005mL\/min) or normal renal function. We used landmark analyses from 12\u2005months after PCI with Cox proportional hazards multivariable and propensity-adjusted models to assess the effect of prolonged clopidogrel (more than 12\u2005months) versus 12 months or less after PCI on clinical outcomes from 1 year to 4\u2005years after PCI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 23\u2005042 eligible subjects receiving PCI, 4880 (21%) had CKD. Compared with normal renal function, patients with CKD had higher risks of death or MI 1\u20134\u2005years after DES (21% vs 12%, HR=1.75; 95% CI 1.51 to 2.04) or BMS (28% vs 15%, HR=2.10; 95% CI 1.90 to 2.32). In patients with CKD receiving DES, clopidogrel use of more than 12\u2005months after PCI was associated with lower risks of death or MI (18% vs 24%, HR=0.74; 95% CI 0.58 to 0.95), and death (15% vs 23%, HR=0.61; 95% CI 0.47 to 0.80), but had no effect on repeat revascularisation 1\u20134\u2005years after PCI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In patients with CKD, prolonging clopidogrel beyond 12\u2005months after PCI may decrease the risk of death or MI only in patients receiving first-generation DES. These results support a patient-tailored approach to prolonging clopidogrel after PCI.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2014-307168","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T02:57:56Z","timestamp":1441940276000},"page":"1569-1576","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease"],"prefix":"10.1136","volume":"101","author":[{"given":"Omar K","family":"Siddiqi","sequence":"first","affiliation":[{"name":"Cardiovascular Division, Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA"},{"name":"Cardiovascular Division, Boston Medical Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle J","family":"Smoot","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA"},{"name":"MAVERIC, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa B","family":"Dufour","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA"},{"name":"MAVERIC, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Cho","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA"},{"name":"MAVERIC, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Young","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA"},{"name":"MAVERIC, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R","family":"Gagnon","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA"},{"name":"MAVERIC, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA"},{"name":"Boston University School of Public Health, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Ly","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Temiyasathit","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P","family":"Faxon","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Michael","family":"Gaziano","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA"},{"name":"MAVERIC, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Kinlay","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,7,24]]},"reference":[{"key":"2025092003331324000_101.19.1569.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01745-X"},{"key":"2025092003331324000_101.19.1569.2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000016359.94919.16"},{"key":"2025092003331324000_101.19.1569.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2008.06.012"},{"key":"2025092003331324000_101.19.1569.4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jcin.2012.02.014","article-title":"Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8,061-patient XIENCE V United States study","volume":"5","author":"Naidu","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"2025092003331324000_101.19.1569.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.07.023"},{"key":"2025092003331324000_101.19.1569.6","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.23394"},{"key":"2025092003331324000_101.19.1569.7","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.23484"},{"key":"2025092003331324000_101.19.1569.8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jcin.2011.06.012","article-title":"Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial","volume":"4","author":"Saltzman","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"2025092003331324000_101.19.1569.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2008.05.002"},{"key":"2025092003331324000_101.19.1569.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.06.056"},{"key":"2025092003331324000_101.19.1569.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-011-0347-7"},{"key":"2025092003331324000_101.19.1569.12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-6-201203200-00007"},{"key":"2025092003331324000_101.19.1569.13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.895342"},{"key":"2025092003331324000_101.19.1569.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.10.046"},{"key":"2025092003331324000_101.19.1569.15","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"2025092003331324000_101.19.1569.16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.059022"},{"key":"2025092003331324000_101.19.1569.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.06.043"},{"key":"2025092003331324000_101.19.1569.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001266"},{"key":"2025092003331324000_101.19.1569.19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.071589"},{"key":"2025092003331324000_101.19.1569.20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.111.967257"},{"key":"2025092003331324000_101.19.1569.21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"2025092003331324000_101.19.1569.22","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2025092003331324000_101.19.1569.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.0160.x"},{"key":"2025092003331324000_101.19.1569.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.097014"},{"key":"2025092003331324000_101.19.1569.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409312"},{"key":"2025092003331324000_101.19.1569.26","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.23464"},{"key":"2025092003331324000_101.19.1569.27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.046599"},{"key":"2025092003331324000_101.19.1569.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.01.009"},{"key":"2025092003331324000_101.19.1569.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.01.032"},{"key":"2025092003331324000_101.19.1569.30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.600155"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2014-307168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T10:33:19Z","timestamp":1758364399000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2014-307168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,24]]},"references-count":30,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2015,9,10]]},"published-print":{"date-parts":[[2015,10,1]]}},"alternative-id":["10.1136\/heartjnl-2014-307168"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2014-307168","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,24]]}}}